poloxalene has been researched along with Adenocarcinoma, Basal Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cierniak, A; Komarnicka, UK; Kołoczek, P; Kyzioł, A; Płotek, M; Sebastian, V; Skórska-Stania, A | 1 |
| Dremann, D; Exner, AA; Krupka, TM | 1 |
| Alakhov, VY; Gebhart, C; Kabanov, A; Sriadibhatla, S; Yang, Z | 1 |
3 other study(ies) available for poloxalene and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Polymeric micelle-mediated delivery of half-sandwich ruthenium(II) complexes with phosphanes derived from fluoroloquinolones for lung adenocarcinoma treatment.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cisplatin; Coordination Complexes; DNA Fragmentation; Drug Carriers; Fluoroquinolones; Humans; Inhibitory Concentration 50; Lung Neoplasms; Micelles; Nanoparticles; Phosphines; Poloxalene; Ruthenium | 2018 |
Time and dose dependence of pluronic bioactivity in hyperthermia-induced tumor cell death.
Topics: Adenocarcinoma; Adenosine Triphosphate; Animals; Cell Survival; Hyperthermia, Induced; Kinetics; Mitochondria; Poloxalene; Poloxamer; Rats; Time Factors | 2009 |
Transcriptional activation of gene expression by pluronic block copolymers in stably and transiently transfected cells.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Fibroblasts; Flow Cytometry; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Luciferases; Mammary Neoplasms, Experimental; Maximum Tolerated Dose; Mice; Microscopy, Confocal; Myoblasts; NIH 3T3 Cells; Poloxalene; RNA, Messenger; Time Factors; Transcription, Genetic; Transcriptional Activation; Transfection | 2006 |